323 related articles for article (PubMed ID: 25542899)
1. Crystal structure of DNA cytidine deaminase ABOBEC3G catalytic deamination domain suggests a binding mode of full-length enzyme to single-stranded DNA.
Lu X; Zhang T; Xu Z; Liu S; Zhao B; Lan W; Wang C; Ding J; Cao C
J Biol Chem; 2015 Feb; 290(7):4010-21. PubMed ID: 25542899
[TBL] [Abstract][Full Text] [Related]
2. Molecular Interactions of a DNA Modifying Enzyme APOBEC3F Catalytic Domain with a Single-Stranded DNA.
Fang Y; Xiao X; Li SX; Wolfe A; Chen XS
J Mol Biol; 2018 Jan; 430(1):87-101. PubMed ID: 29191651
[TBL] [Abstract][Full Text] [Related]
3. APOBEC3G Interacts with ssDNA by Two Modes: AFM Studies.
Shlyakhtenko LS; Dutta S; Banga J; Li M; Harris RS; Lyubchenko YL
Sci Rep; 2015 Oct; 5():15648. PubMed ID: 26503602
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications.
Holden LG; Prochnow C; Chang YP; Bransteitter R; Chelico L; Sen U; Stevens RC; Goodman MF; Chen XS
Nature; 2008 Nov; 456(7218):121-4. PubMed ID: 18849968
[TBL] [Abstract][Full Text] [Related]
5. Crystal Structure of a Soluble APOBEC3G Variant Suggests ssDNA to Bind in a Channel that Extends between the Two Domains.
Maiti A; Myint W; Delviks-Frankenberry KA; Hou S; Kanai T; Balachandran V; Sierra Rodriguez C; Tripathi R; Kurt Yilmaz N; Pathak VK; Schiffer CA; Matsuo H
J Mol Biol; 2020 Nov; 432(23):6042-6060. PubMed ID: 33098858
[TBL] [Abstract][Full Text] [Related]
6. Catalytic analysis of APOBEC3G involving real-time NMR spectroscopy reveals nucleic acid determinants for deamination.
Kamba K; Nagata T; Katahira M
PLoS One; 2015; 10(4):e0124142. PubMed ID: 25875164
[TBL] [Abstract][Full Text] [Related]
7. Structural Investigations on the Interactions between Cytidine Deaminase Human APOBEC3G and DNA.
Yan X; Lan W; Wang C; Cao C
Chem Asian J; 2019 Jul; 14(13):2235-2241. PubMed ID: 31116511
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of location- and sequence-dependent deamination by APOBEC3G using real-time NMR spectroscopy.
Furukawa A; Sugase K; Morishita R; Nagata T; Kodaki T; Takaori-Kondo A; Ryo A; Katahira M
Angew Chem Int Ed Engl; 2014 Feb; 53(9):2349-52. PubMed ID: 24478136
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of APOBEC3G N-domain alone and its complex with DNA.
Xiao X; Li SX; Yang H; Chen XS
Nat Commun; 2016 Aug; 7():12193. PubMed ID: 27480941
[TBL] [Abstract][Full Text] [Related]
10. Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA.
Friew YN; Boyko V; Hu WS; Pathak VK
Retrovirology; 2009 Jun; 6():56. PubMed ID: 19497112
[TBL] [Abstract][Full Text] [Related]
11. Dimerization regulates both deaminase-dependent and deaminase-independent HIV-1 restriction by APOBEC3G.
Morse M; Huo R; Feng Y; Rouzina I; Chelico L; Williams MC
Nat Commun; 2017 Sep; 8(1):597. PubMed ID: 28928403
[TBL] [Abstract][Full Text] [Related]
12. Deaminase activity on single-stranded DNA (ssDNA) occurs in vitro when APOBEC3G cytidine deaminase forms homotetramers and higher-order complexes.
McDougall WM; Okany C; Smith HC
J Biol Chem; 2011 Sep; 286(35):30655-30661. PubMed ID: 21737457
[TBL] [Abstract][Full Text] [Related]
13. DNA mutagenic activity and capacity for HIV-1 restriction of the cytidine deaminase APOBEC3G depend on whether DNA or RNA binds to tyrosine 315.
Polevoda B; Joseph R; Friedman AE; Bennett RP; Greiner R; De Zoysa T; Stewart RA; Smith HC
J Biol Chem; 2017 May; 292(21):8642-8656. PubMed ID: 28381554
[TBL] [Abstract][Full Text] [Related]
14. Structure of the Vif-binding domain of the antiviral enzyme APOBEC3G.
Kouno T; Luengas EM; Shigematsu M; Shandilya SM; Zhang J; Chen L; Hara M; Schiffer CA; Harris RS; Matsuo H
Nat Struct Mol Biol; 2015 Jun; 22(6):485-91. PubMed ID: 25984970
[TBL] [Abstract][Full Text] [Related]
15. Structural model for deoxycytidine deamination mechanisms of the HIV-1 inactivation enzyme APOBEC3G.
Chelico L; Prochnow C; Erie DA; Chen XS; Goodman MF
J Biol Chem; 2010 May; 285(21):16195-205. PubMed ID: 20212048
[TBL] [Abstract][Full Text] [Related]
16. An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model.
Harjes E; Gross PJ; Chen KM; Lu Y; Shindo K; Nowarski R; Gross JD; Kotler M; Harris RS; Matsuo H
J Mol Biol; 2009 Jun; 389(5):819-32. PubMed ID: 19389408
[TBL] [Abstract][Full Text] [Related]
17. Atomic force microscopy studies of APOBEC3G oligomerization and dynamics.
Shlyakhtenko LS; Lushnikov AY; Miyagi A; Li M; Harris RS; Lyubchenko YL
J Struct Biol; 2013 Nov; 184(2):217-25. PubMed ID: 24055458
[TBL] [Abstract][Full Text] [Related]
18. RNA-binding residues in the N-terminus of APOBEC3G influence its DNA sequence specificity and retrovirus restriction efficiency.
Bélanger K; Langlois MA
Virology; 2015 Sep; 483():141-8. PubMed ID: 25974865
[TBL] [Abstract][Full Text] [Related]
19. Atomic force microscopy studies provide direct evidence for dimerization of the HIV restriction factor APOBEC3G.
Shlyakhtenko LS; Lushnikov AY; Li M; Lackey L; Harris RS; Lyubchenko YL
J Biol Chem; 2011 Feb; 286(5):3387-95. PubMed ID: 21123176
[TBL] [Abstract][Full Text] [Related]
20. RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1.
Huthoff H; Autore F; Gallois-Montbrun S; Fraternali F; Malim MH
PLoS Pathog; 2009 Mar; 5(3):e1000330. PubMed ID: 19266078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]